We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
SiteOne Therapeutics announced the company has been awarded a $1.4 million, two-year, Phase 2 SBIR grant from the National Eye Institute (NEI), a member of the US National Institutes of Health (NIH).